FLSM
Frazier Life Sciences Management Portfolio holdings
AUM
$2.5B
This Quarter Return
+2.24%
1 Year Return
+52.94%
3 Year Return
+530.54%
5 Year Return
–
10 Year Return
–
AUM
$2.19B
AUM Growth
+$2.19B
(-9.2%)
Cap. Flow
-$90.6M
Cap. Flow
% of AUM
-4.14%
Top 10 Holdings %
Top 10 Hldgs %
70.17%
Holding
54
New
4
Increased
10
Reduced
8
Closed
7
Top Buys
| 1 |
MAZE
Maze Therapeutics, Inc. Common Stock
MAZE
|
$45.5M |
| 2 |
Avidity Biosciences
RNA
|
$15.5M |
| 3 |
Dyne Therapeutics
DYN
|
$15.1M |
| 4 |
Zai Lab
ZLAB
|
$12.6M |
| 5 |
Mirum Pharmaceuticals
MIRM
|
$10.1M |
Top Sells
| 1 |
Rhythm Pharmaceuticals
RYTM
|
$63.1M |
| 2 |
Edgewise Therapeutics
EWTX
|
$33.9M |
| 3 |
AnaptysBio
ANAB
|
$20.8M |
| 4 |
Krystal Biotech
KRYS
|
$18M |
| 5 |
Pliant Therapeutics
PLRX
|
$14.8M |
Sector Composition
| 1 | Healthcare | 99.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Arvinas
ARVN
$568M
| – | – | -285,331 | Closed | -$5.47M |
|
52
89bio
ETNB
$1.34B
| – | – | -1,000,000 | Closed | -$7.82M |
|
|
53
Edgewise Therapeutics
EWTX
$1.51B
| – | – | -1,271,245 | Closed | -$33.9M |
|
|
54
Pliant Therapeutics
PLRX
$101M
| – | – | -1,120,803 | Closed | -$14.8M |
|